Based on droplet microfluidics technology, it integrates four core modules to achieve micro-volume high-throughput automation, addressing critical pain points in organoid research, and empowering drug discovery (cost reduction for compound testing in biobanks) and precision medicine (patient tissue modeling, immunotherapy evaluation).